Bionomics (BNOX)
(Delayed Data from NSDQ)
$0.28 USD
+0.01 (3.63%)
Updated Oct 11, 2024 03:58 PM ET
After-Market: $0.29 +0.01 (3.61%) 4:52 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
BNOX 0.28 +0.01(3.63%)
Will BNOX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for BNOX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BNOX
Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals
BNOX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BNOX
12 Health Care Stocks Moving In Friday's Pre-Market Session
Aaron Weaver Ends Tenure on Bionomics Board
Bionomics CEO believes company has 'significant, unrealized value'
Bionomics Limited announces intention to re-domicile to the United States
Bionomics intends to re-domicile to the U.S.